1. Market Research
  2. > Healthcare Market Trends
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

  • May 2017
  • 228 pages
  • ID: 1544030
In this report:
In 2016, the company reported net sales of $##.## billion, of which the company generated ##% from emerging growth markets and ##% from established markets (the US, Canada, Western Europe, Japan, Australia and New Zealand).
Its medical device sales in 2016 totaled $##.## billion, a decrease of ##.##% from 2015, which included an operational increase of ##.##% and a negative currency impact of ##%.

Summary

Table of Contents

Search Inside

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

Brief

Germany (DE) has a mature healthcare market established on its high healthcare expenditure and pharmaceutical production. The increasingly elderly population and its associated disease burden are anticipated to drive the growth of the pharmaceutical market, while government initiatives to reduce healthcare expenditure will limit increase.

The value of the German pharmaceuticals market increased from EUR37.3 Billion (US$54.7 Billion) in 2008 to EUR43.3 Billion (US$57.6 Billion) in 2013 at a Compound Annual Growth Rate of 1.00 percent. In US dollar terms, the industry declined from US$54.7 Billion in 2008 to US$51.2 Billion in 2012 at a negative Compound annual growth rate of 1.70 percent due to frequent currency devaluation. The value of the pharmaceuticals market is anticipated to reach US$65 Billion in 2020 from US$58.6 Billion in 2014, growing at a CAGR (Compound annual growth rate) of 1.70 percent (Federal Health Reporting, 2014c). Germany (DE) is the most important healthcare market among the EU member states.

The German medical device market was valued at US$18.9 Billion in 2008, which increased to US$23.8 Billion in 2013, and is anticipated to grow at a compound annual growth rate (CAGR) of 5.60 percent from US$24.8 Billion in 2014 to US$34.4 Billion in 2020. The principal segments and orthopedics devices, wound care management, and hospital supplies) will drive market increase.

The sector is driven by the following factors -

Germany (DE) has been witnessing constant economic growth despite its meaningful contribution to the bailout of the EU states including Greece, Ireland, Portugal (PT) and Cyprus. This is due largely to the existence of a strong political environment. The coalition government of Christian Democratic Union and the Christian Social Union led by the Chancellor Angela Merkel has been in power since 2005. This has enabled the government to fully implement its policies. Germany (DE) is the biggest economy in Europe (EU) and has played a critical role in finding a solution to the eurozone debt crisis. The International Monetary Fund forecasts that over the next five to seven years, GDP per capita will register a steady increase as a result of government efforts.

The analysis "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany (DE)", offers data on the healthcare, regulatory, and reimbursement landscape in Germany (DE). In depth, it offers the following analysis -

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and main drivers and barriers.

- Profiles and SWOT analyses of the main players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the main players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun).

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for additional drugs and medical devices.

- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure.

- An overview of the opportunities for and challenges to growth in the German healthcare market.

Corporations mentioned in this business report: AstraZeneca, Pfizer, Teva, Eli Lilly, Novo Nordisk, Merck, Pfizer, Amgen, Otsuka, Merck, Sanofi-Aventis, Endo, Novartis, Schering-Plough, GSK, Schering-Plough, Novartis, Novartis.

Overview

The study offers info on the healthcare, regulatory, and reimbursement landscape in Germany (DE), and includes -

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and top drivers and barriers

- Profiles and SWOT analyses of the main players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the main players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun)

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for additional drugs and medical devices

- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the German healthcare market

Great reasons to purchase

This industry report will enhance your decision-making capability by allowing you to -

- Develop strategic management by understanding the trends shaping and driving German healthcare market

- Drive revenues by understanding the main trends, reimbursement and regulatory policies, pharmaceutical market segments, and firms likely to impact the healthcare market in the coming years

- Specified effective sales and marketing strategies by understanding the ambitious landscape and analyzing the performance of different competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and tactical partnership

- Identify, comprehend, and exploit the opportunities and challenges in German healthcare market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Healthcare Fraud Detection Market by Type, Application, Component, Delivery, End user - Global Forecast to 2022

Healthcare Fraud Detection Market: Global Forecast until 2022

  • $ 6328
  • Industry report
  • January 2018
  • by MarketsandMarkets

Global healthcare fraud detection market projected to grow at a CAGR of 28.9%The healthcare fraud detection market is expected to reach USD 2,242.7 million by 2022 from USD 631.0 million in 2017, at a ...

Clinical Laboratory Services Market by Specialty, Providers - Global Forecasts to 2022

Clinical Laboratory Services Market: Global Forecasts until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

Clinical laboratory services market projected to grow at a CAGR of 5.2%The clinical laboratory services market is projected to reach USD 146.14 billion by 2022 from USD 113.44 billion in 2017, at a CAGR ...

Healthcare Analytics/Medical Analytics Market by Type Application Component Delivery End User - Global Forecast to 2022

Healthcare Analytics/Medical Analytics Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

Global healthcare analytics market projected to grow at a CAGR of 27.3%The healthcare analytics market is expected to reach USD 29.84 billion by 2022 from USD 8.92 billion in 2017, at a CAGR of 27.3%. ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.